DETERMINATION OF CARBAMAZEPINE— 510(k) K860047

Substantially Equivalent

Clinical Data, Inc.

FDA 510(k) clearance K860047 for DETERMINATION OF CARBAMAZEPINE, Substantially Equivalent on 1986-01-22. Applicant: Clinical Data, Inc.. Device class: 2.

Clearance details

Applicant
Clinical Data, Inc.
Product code
Code KLT
Device class
Class 2
Regulation
21 CFR 862.3645
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Boston, MA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code KLT

view all

More clearances from Clinical Data, Inc.

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.